Price (delayed)
$131.32
Market cap
$19.22B
P/E Ratio
11.71
Dividend/share
N/A
EPS
$11.21
Enterprise value
$23.48B
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide.
There are no recent dividends present for BIIB.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from and Sharadar.